Literature DB >> 3109535

Cytoprotective effects of disodium cromoglycate on rat stomach mucosa.

J Goossens, J Van Reempts, J P Van Wauwe.   

Abstract

The cytoprotective effects of the anti-asthmatic drug, disodium cromoglycate (DSCG), on gastric mucosal necrosis induced by ethanol in rats were studied. Subcutaneous, but not oral, DSCG prevented the formation of gastric lesions and this effect was dose-dependent between 1.25 and 40 mg kg-1, with an ED50 value of 6.8 mg kg-1. Maximal cytoprotection occurred 15-30 min after DSCG treatment. Histological examination revealed that DSCG effectively protected the gastric mucosa against ethanol-induced vascular congestion, haemorrhage, epithelial desquamation and mucosal oedema. Enhanced production of endogenous prostaglandins, which are known cytoprotective compounds, could not explain the mucosal protection. At a dose of 40 mg kg-1, DSCG did not change prostaglandin E2 or 6-keto-prostaglandin F1 alpha concentrations in gastric mucosal tissue, although its cytoprotective activity was partially inhibited by prior treatment of the animals with indomethacin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109535      PMCID: PMC1853475          DOI: 10.1111/j.1476-5381.1987.tb08995.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  The pathology of asthma, with special reference to changes in the bronchial mucosa.

Authors:  M S DUNNILL
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

2.  The fate of ( 14 C)disodium cromoglycate in man.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

Review 3.  Bronchial hyperreactivity.

Authors:  H A Boushey; M J Holtzman; J R Sheller; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1980-02

4.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

5.  Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin.

Authors:  E R Lacy; S Ito
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

6.  Ultrastructure of airways in children with asthma.

Authors:  E Cutz; H Levison; D M Cooper
Journal:  Histopathology       Date:  1978-11       Impact factor: 5.087

7.  Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma?

Authors:  G S Basran; C P Page; W Paul; J Morley
Journal:  Eur J Pharmacol       Date:  1982-12-17       Impact factor: 4.432

8.  Salicylic acid blocks indomethacin- and aspirin-induced cyclo-oxygenase inhibition in rat gastric mucosa.

Authors:  M Ligumsky; D G Hansen; G L Kauffman
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

9.  Randomised placebo-controlled double-blind trial of two dosages of sodium cromoglycate in treatment of varioliform gastritis: comparison with cimetidine.

Authors:  C André; J Gillon; B Moulinier; A Martin; M C Fargier
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

10.  Pharmacologic profile of a new antiallergic compound PRD-92-Ea.

Authors:  J El-Azab; P B Stewart
Journal:  Int Arch Allergy Appl Immunol       Date:  1977
View more
  3 in total

1.  Gastroprotective and ulcer healing profile of the mast cell stabilizer quazolast in rats.

Authors:  L R Fitzpatrick; D L Decktor
Journal:  Agents Actions       Date:  1991-07

2.  Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice.

Authors:  A Minocha; C Thomas; R Omar
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

3.  Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.

Authors:  Y Tabuchi; K Kawarabayashi; K Furuhama
Journal:  Agents Actions       Date:  1994-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.